Open AccessT cell-inflamed gene expression profile and PD-L1 expression and pembrolizumab efficacy in advanced esophageal cancer
Author(s) -
Manish A. Shah,
Takashi Kojima,
Daniel Hochhauser,
Peter C. Enzinger,
Judith Raimbourg,
Antoine Hollebecque,
Florian Lordick,
SungBae Kim,
Masahiro Tajika,
A. Craig Lockhart,
Hendrick-Tobias Arkenau,
Farid El-Hajbi,
Mukul Gupta,
Per Pfeiffer,
Pooja Bhagia,
Z. Alexander Cao,
Jared Lunceford,
Shailaja Suryawanshi,
Mark Ayers,
Matthew J. Marton,
Ken Kato
Publication year - 2022
Publication title -
future oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.857
H-Index - 72
eISSN - 1744-8301
pISSN - 1479-6694
DOI - 10.2217/fon-2021-1134
Subject(s) - pembrolizumab , medicine , adenocarcinoma , oncology , esophageal cancer , esophageal squamous cell carcinoma , esophagus , cancer , carcinoma , pd l1 , immunohistochemistry , immunotherapy